“B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM” (2014) Journal of Cancer Research Updates, 3(1), pp.  59–66. doi:10.6000/1929-2279.2014.03.01.6.